StockData
Agentix Corp. logo

Agentix Corp. (AGTX) stock

AGTXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 0/30
$0.02+0.00 (0.00%)

Close on Oct 16, 2026Market cap $801.34KP/E –Yield –

Earnings

Agentix's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Agentix's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Agentix has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Agentix puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Agentix filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?